Comparison |
Application |
Microbiology Reagent | Immunoassay Reagent | Molecular Reagent | General Chemistry Reagent | General Chemistry Reagent |
CLIA Classification |
| CLIA Non-Waived | | | |
CLIA Classified |
| CLIA Non-Waived | | | |
Country of Origin |
Unknown | United States | United States | United States | United States |
For Use With |
For VITEK 2 System | For BD Viper Instrument | For BD Viper Instrument | For ACE Axcel / ACE Alera Clinical Chemistry Systems | For ACE Axcel / ACE Alera Clinical Chemistry Systems |
Number of Tests |
60 Tests | 1,152 Tests | 1,152 Tests | 450 Tests | 450 Tests |
Product Dating |
McKesson Acceptable Dating: we will ship >= 60 days | McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
Sample Type |
| Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Sample | Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Sample | Serum / Plasma Sample | Serum / Plasma Sample |
Specialty |
Microbiology | Immunoassay | Molecular | General Chemistry | General Chemistry |
Storage Requirements |
Requires Refrigeration | | | Requires Refrigeration | Requires Refrigeration |
Test Category |
Susceptibility Testing | Sexual Health | Sexual Health | General Chemistry | General Chemistry |
Test Format |
Test Card | | | | |
Test Method |
Gram Positive Organisms | Amplified DNA Assay | | | |
Test Name |
AST-GP82 | Chlamydia Trachomatis / Neisseria Gonorrhoeae (CT / NG) | Neisseria Gonorrhoea (NG) | Alanine Aminotransferase (ALT) | Aspartate Aminotransferase (AST) |
Test Type |
Identification and Susceptibility Testing | Infectious Disease | DNA Amplification / Detection | Hepatic | Hepatic |
UNSPSC Code |
41116129 | 41116011 | 41116011 | 41116105 | 41116105 |
Volume |
| 1,152 Tests | | | R1: 3 X 12 mL, R2: 3 X 12 mL |
Features and Benefits |
- The VITEK® 2 Gram-positive Susceptibility Card is intended for use with the VITEK® 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed
|
- Qualitative detection of Chlamydia trachomatis DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
- Qualitative detection of Neisseria gonorrhoeae DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
- For the quantitative determination of alanine aminotransferase activity in serum and lithium heparin plasma
|
- For the quantitative determination of aspartate aminotransferase activity in serum and lithium heparin plasma
|